Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Robert A. Vukovich"'
Autor:
Stephanie Beling, Max Losi, Robert A Vukovich, Martin Zisblatt, Edmund L Webb, Edward S. Neiss
Publikováno v:
American Heart Journal. 106:258-262
Indapamide, 2.5 mg administered once daily for periods up to 36 months, was found to be safe and effective for the long-term control of mild to moderate hypertension. The effects of hydrochlorothiazide, 50 mg, and indapamide, 2.5 mg, were studied in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ceadbe805f45e3f17476df68df20bc60
https://doi.org/10.1016/0002-8703(83)90126-6
https://doi.org/10.1016/0002-8703(83)90126-6
Publikováno v:
The Journal of Clinical Pharmacology. 17:300-307
Nadolol-14C, 2,3-cis-5-(3-[(1,1-dimethylethyl)amino]-2-hydroxypropoxy)-1,2,3,4-tetrahydro-2,3-naphthalenediol, a nonselective beta-adrenergic blocking agent, was administered orally and intravenously at 2-mg doses to patients with mild cases of essen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a7da0970be97a560fa976d6e75e8057
https://doi.org/10.1002/j.1552-4604.1977.tb04609.x
https://doi.org/10.1002/j.1552-4604.1977.tb04609.x
Autor:
Hans R. Brunner, Doris N. McKinstry, Irene Gavras, Charles P. Tifft, Sergio Cuttelod, Robert A. Vukovich, Gustave A. Turini, Glenn R. Kershaw, Haralambos Gavras
Publikováno v:
New England Journal of Medicine. 298:991-995
We investigated the antihypertensive effect of the angiotensin converting-enzyme inhibitor SQ 14225 in 12 hypertensive patients for periods of three to 24 weeks. Blood pressure decreased in all patients (from 177 +/- 8/110 +/- 2 to 136 +/- 6/88 +/- 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5168f06e4407b5ccceb4086b65d863b2
https://doi.org/10.1056/nejm197805042981803
https://doi.org/10.1056/nejm197805042981803
Autor:
Irene Gavras, John H. Laragh, Robert A. Vukovich, Jean E. Sealey, Haralambos Gavras, Hans R. Brunner
Publikováno v:
New England Journal of Medicine. 291:817-821
The antihypertensive action of nonapeptide competitive inhibitor of angiotensin-1-converting enzyme was evaluated in 13 hypertensive patients. In 12 a single injection (1 to 4 mg per kilog...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39bc0203e45771b959361ba786360f5
https://doi.org/10.1056/nejm197410172911603
https://doi.org/10.1056/nejm197410172911603
Autor:
Robert Rosenbaum, Edward S. Neiss, Martin Zisblatt, Edmund L Webb, John C Godfrey, Robert A Vukovich
Publikováno v:
Journal of International Medical Research. 12:147-153
The efficacy of a once-daily combination of chlorthalidone 50 mg plus triamterene 50 mg or chlorthalidone 100 mg plus triamterene 100 mg was compared to that of chlorthalidone 50 mg or 100 mg. This double-blind study was carried out in eighty-eight p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07cbf65e2c69757b4621de169efb9264
https://doi.org/10.1177/030006058401200303
https://doi.org/10.1177/030006058401200303
Publikováno v:
American Heart Journal. 106:212-220
Indapamide is a new antihypertensive diuretic agent indicated for the treatment of hypertension and edema. Indapamide shows an alteration in vascular reactivity to calcium and other agonists, suggesting the possibility of a direct vascular effect. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17bff19ea37907a76425f095ff6ede05
https://doi.org/10.1016/0002-8703(83)90119-9
https://doi.org/10.1016/0002-8703(83)90119-9
Autor:
Haralambos Gavras, Hans R. Brunner, Robert A. Vukovich, Irene Gavras, Gustave A. Turini, Doris N. McKinstry, Bernard Waeber
1 Captopril (SQ14,225), an orally active inhibitor of angiotensin- converting enzyme, was administered to nine patients with essential hypertension. Plasma renin activity (PRA) was low in four, 'normal' in three and high in two patients. 2 In the hos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e3afe2218b68f9cd52d69764001bda3d
https://europepmc.org/articles/PMC1429327/
https://europepmc.org/articles/PMC1429327/
Autor:
Robert A. Vukovich, James R. Knill
Publikováno v:
Captopril and Hypertension ISBN: 9781461591818
The circulatory system is a closed-loop system in which cardiac output is dependent upon adequate venous return. Distribution of this output to the various organ systems in amounts appropriate to their needs is accomplished by constriction or relaxat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::095af4083486b6b85276f7f93ddc64bd
https://doi.org/10.1007/978-1-4615-9179-5_1
https://doi.org/10.1007/978-1-4615-9179-5_1
Autor:
Haralambos Gavras, M Porchet, Robert A. Vukovich, Gustave A. Turini, D Kruithof, Michel Burnier, H. R. Brunner
Publikováno v:
British journal of clinical pharmacology. 12(6)
1 The new converting enzyme inhibitor RHC 3659 was tested in 15 male volunteers. The study consisted of two parts: first, the ability of a single oral dose (5, 10, 20, 40 or 80 mg) to inhibit the pressor response to exogenous angiotensin I was tested
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2ae1fcf6c75b5abb1fdebc4e6fa7cd8
https://pubmed.ncbi.nlm.nih.gov/6280740
https://pubmed.ncbi.nlm.nih.gov/6280740
Publikováno v:
The Journal of international medical research. 5(1)
One of several novel peptidic inhibitors of angiotensin converting enzyme (CEI) has been studied intravenously both in normal male volunteers and severely hypertensive patients without any clinically significant adversity or intolerance. Hypertensive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b02244264bd3f7d219fc395ee42b41b
https://pubmed.ncbi.nlm.nih.gov/190063
https://pubmed.ncbi.nlm.nih.gov/190063